Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Cancer Immunology, Immunotherapy : CII|September 5, 2019
A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patientsBenjamin Weide, Thomas Eigentler, Chiara Catania, et al.Melanoma Research|July 18, 2006
Basal level and behaviour of cytokines in a randomized outpatient trial comparing chemotherapy and biochemotherapy in metastatic melanomaMichele Guida, Angela Riccobon, Guido Biasco, et al.International Journal of Environmental Research and Public Health|March 6, 2021
Melanoma Prevention: Comparison of Different Screening Methods for the Selection of a High Risk PopulationNevio Dubbini, Antonella Puddu, Grazia Salimbeni, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2011
A dose-escalation and signal-generating study of the immunocytokine L19-IL2 in combination with dacarbazine for the therapy of patients with metastatic melanomaThomas K Eigentler, Benjamin Weide, Filippo de Braud, et al.Journal of Experimental & Clinical Cancer Research : CR|November 3, 2012
The cost of unresectable stage III or stage IV melanoma in ItalyMichele Maio, Paolo Ascierto, Alessandro Testori, et al.Cancers|April 3, 2021
Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma GroupEmanuela Palmerini, Roberta Sanfilippo, Giovanni Grignani, et al.Journal of the American Academy of Dermatology|June 9, 2009
Clinical genetic testing for familial melanoma in Italy: a cooperative studyWilliam Bruno, Paola Ghiorzo, Linda Battistuzzi, et al.Frontiers in Oncology|December 26, 2022
Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a post-hoc analysisEmanuela Palmerini, Roberta Sanfilippo, Giovanni Grignani, et al.The Lancet. Child & Adolescent Health|March 16, 2019
MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohortCristina Pellegrini, Francesca Botta, Daniela Massi, et al.Pageof 4